Helen Tager-Flusberg is director of the Center for Autism Research Excellence at Boston University. Her research aims to untangle autism and language impairments using behavioral and brain-imagining studies. She was also a columnist for Spectrum.
Helen Tager-Flusberg
Boston University
From this contributor
Why no one needs a diagnosis of ‘social communication disorder’
A diagnosis of social communication disorder only keeps people from a community and resources they desperately want and need.
Why no one needs a diagnosis of ‘social communication disorder’
By
Helen Tager-Flusberg
17 April 2018 | 1 min read
Should scientists study mothers of children with autism?
Studying parents of children with autism has long been controversial, but that doesn’t mean scientists should avoid it.
Should scientists study mothers of children with autism?
By
Helen Tager-Flusberg
12 April 2016 | 1 min read
‘Frozen’ offers glimpse of autism in girls
Elsa, the star of the movie “Frozen,” is the poster child for girls with autism.
‘Frozen’ offers glimpse of autism in girls
By
Helen Tager-Flusberg
15 September 2015 | 4 min read
Time for some soul-searching in science
Scientists should slow down and return to the basic tenets of research to regain the public’s trust.
Time for some soul-searching in science
By
Helen Tager-Flusberg
1 September 2015 | 1 min read
Better behavioral tests may save trials of autism treatments
Trials to test drugs for autism suffer from subjective measurements and placebo effects. Helen Tager-Flusberg outlines how to ferret out the true effects of potential autism therapies.
Better behavioral tests may save trials of autism treatments
By
Helen Tager-Flusberg
21 April 2015 | 1 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read